Fidson Healthcare shareholders have approved a ₦3.6 billion dividend after the company posted a record ₦119.06 billion annual revenue, becoming Nigeria’s first pharmaceutical firm to surpass the ₦100 billion revenue milestone. Wengglobal examines the significance for investors and Africa’s healthcare industry.